Lumina Fund Management LLC Amgen Inc Transaction History

Lumina Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $994,400 - $1.14 Million	-5,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $350,370 - $388,710	-1,500 Reduced 23.08%	5,000 $1.22 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.41 Million - $1.67 Million	6,500 New	6,500 $1.49 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $911,200 - $1.21 Million	-5,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $267,600 - $312,375	-1,500 Reduced 23.08%	5,000 $960,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $10.3 Million - $11.6 Million	-55,400 Reduced 89.5%	6,500 $1.35 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $10.4 Million - $11.8 Million	61,900	61,900 $11.5 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lumina Fund Management LLC with notifications on news.